Showing results (111-120 of 436) with videos related to

Sort By:
Pageof 44
Wiener Klinische Wochenschrift|January 3, 2012
Effects of 18β-Glycyrrhetinic acid in hTNFtg mice - a model of rheumatoid arthritisAntonia Puchner, Silvia Hayer, Birgit Niederreiter, et al.
Inflammatory Bowel Diseases|February 26, 2011
Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARERobert Löfberg, Edouard V Louis, Walter Reinisch, et al.
Scandinavian Journal of Gastroenterology|April 23, 2015
A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel diseaseWalter Reinisch, Istvan Altorjay, Ferenc Zsigmond, et al.
Inflammatory Bowel Diseases|December 30, 2021
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs AdalimumabParambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
The American Journal of Gastroenterology|October 24, 2003
Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatmentAlexander Teml, Verena Kratzer, Barbara Schneider, et al.
Advances in Therapy|November 10, 2021
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab BiosimilarWalter Reinisch, Stanley Cohen, Monica Ramchandani, et al.
World Journal of Gastroenterology|November 28, 2018
Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic reviewJulian Panes, Walter Reinisch, Ewa Rupniewska, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates|October 2, 2018
A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient GroupsJeremy Yongwen Ng, Usha Chauhan, David Armstrong, et al.
Pageof 44